Compounds > n-palmitoylsphingosine

n-palmitoylsphingosine and Non-alcoholic Fatty Liver Disease

n-palmitoylsphingosine has been researched along with Non-alcoholic Fatty Liver Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Angaji, SA; Baghaei, K; Hatami, B; Majd, A; Rahimi, S1

Other Studies

1 other study(ies) available for n-palmitoylsphingosine and Non-alcoholic Fatty Liver Disease

ArticleYear
Evaluating the effect of basic fibroblast growth factor on the progression of NASH disease by inhibiting ceramide synthesis and ER stress-related pathways.
    European journal of pharmacology, 2023, Mar-05, Volume: 942

    Topics: Animals; Ceramides; Fibroblast Growth Factor 2; Inflammation; Liver; Male; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Reactive Oxygen Species; RNA, Messenger

2023